Global Pulmonary Drugs Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global pulmonary drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to fuel the market growth include a rise in the prevalence of chronic diseases such as bronchitis, tuberculosis, and chronic obstructive pulmonary disease and a rise in tobacco smoking. Pulmonary drug delivery systems deliver drugs to the lung for the treatment of respiratory tract diseases. This route is preferred broadly owing to the non-invasive technique, high blood circulation, large surface area for absorption, and permeability rate. Recent advancements in pulmonary drug delivery devices and methods, rise in gastrointestinal upset, respiratory diseases, and minimum dose requirement are the driving factors that will accelerate the growth of the market during the forecast period.
To Request a Sample of our Report on Global Pulmonary
Drugs Market: https://www.omrglobal.com/request-sample/pulmonary-drugs-market
Moreover, rising incidences of chronic respiratory
diseases will surge the demand for pulmonary drugs. As per the Global Asthma
Report 2018, around 339 million people are affected by Asthma globally. The
significant increase in the targeted patient pool will promote the demand for
pulmonary drugs. Furthermore, R&D associated with the pulmonary drugs
coupled with government and non-government initiatives will create lucrative
opportunities for the market in the coming years, which in turn are expected to
boost the market growth during the forecast period. For instance, CDC’s
National Asthma Control Program (NACP) provides funds for educating
asthma-affected patients. Such initiatives are likely to raise awareness about
asthma, which will increase the adoption of pulmonary drugs in the treatment of
chronic obstructive pulmonary disease (COPD) and asthma, leading to the growth
of the global pulmonary drugs market.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: GlaxoSmithKline plc, Boehringer Ingelheim
GmbH, Novartis AG, Merck & Co., Inc., and AstraZeneca plc.
(Get 15% Discount on Buying this Report)
A
full Report of Global Pulmonary Drugs Market is Available at: https://www.omrglobal.com/industry-reports/pulmonary-drugs-market
Global Pulmonary Drugs Market Report by Segment
By Drug Class
• Beta-2 Agonists
• Anticholinergic Agents
• Oral and Inhaled
Corticosteroids
• Anti-leukotrienes
• Antihistamines
• Monoclonal Antibodies
• Combination Drugs
• Others
By Indication
• Asthma
• COPD (Chronic
Obstructive Pulmonary Disease
• Allergic Rhinitis
• Pulmonary Arterial
Hypertension
• Cystic Fibrosis
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Others
Global Pulmonary Drugs Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment